Trials / Completed
CompletedNCT03972371
The ProVerum First in Man PROVE Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- ProVerum Medical · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
A clinical evaluation to assess the safety and performance of the ProVeeTM Urethral Expander System, designed to alleviate the symptoms of Benign Prostatic Hyperplasia (BPH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The ProVee Urethral Expander System | The ProVee Urethral Expander System is supplied as a single use, sterile device and consists of a nitinol expander implant and custom implant delivery system. The delivery system is designed to allow the implant to be deployed under direct vision. |
Timeline
- Start date
- 2019-05-13
- Primary completion
- 2021-12-01
- Completion
- 2023-11-27
- First posted
- 2019-06-03
- Last updated
- 2023-11-28
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03972371. Inclusion in this directory is not an endorsement.